In the News

NHS launches World’s Largest Trial of Cancer Blood Test

The National Health Service (NHS) in the United Kingdom has announced the world’s largest trial of GRAIL’s Galleri blood test, which was developed to detect more than 50 types of cancer before symptoms appear. The NHS hopes to recruit 140,000 volunteers across the UK to participate in the trial. “This quick and...

Aetion and Quinten Health partner to use AI and RWE to reduce research timelines

Aetion and Quinten Health have partnered up to better provide a range of real-world evidence (RWE) generation products and services by reducing complexity, increasing efficiency, and supporting rapid turnaround times to improve patient outcomes. Aetion Co-Founder and President Jeremy Rassen said the partnership will...

Aledade Named Among 2021 Best Workplaces for Women by FORTUNE and Great Place to Work

FORTUNE and Great Place to Work have ranked Aledade as one of 2021’s Best Workplaces for Women. Ranked 12th on the list, it’s Aledade’s second year in a row receiving the honor. The annual FORTUNE and Great Place to Work awards are based on survey responses from employees, an analysis which includes over 5.6 million...

Xealth Secures $24 Million in Series B Funding to Accelerate Digital Health

Xealth has announced an additional $24 million in Series B funding, bringing its total raised to $52.6 million. The funding round was led by Advocate Aurora Enterprises, with additional participation from seven health systems--Banner Health, ChristianaCare, Cone Health, Memorial Hermann, Nebraska Medicine, Novant...

Oncology Analytics Announces Rebrand to OncoHealth

Oncology Analytics has changed its name to OncoHealth, a forward-looking rebrand for the company’s vision of the future and its focus on helping people through their cancer journey. "OncoHealth represents our evolution of better aligning the way we serve clients and the way our clients access digital health solutions...

New multi-cancer early detection blood test study opens

The University of Oxford has opened a new study, which will trial a new multi-cancer early detection (MCED) blood test for early detection of more than 50 types of cancer. The study, SYMPLIFY, is also open at Oxford University Hospitals (OUH) and already includes more than 500 participants. That number could double...

Press Releases

Survey Says Moms Want In-Person Care With a Side of Digital Health

Digital health company Xealth announced a recent survey examining new mothers and their expectations for digital health in comparison with the healthcare services they received. The survey was conducted among over 1,000 new or expectant mothers, with 57 percent of...